4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Cardiac Implantable Electronic Devices | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Background The extravascular implantable cardioverter–defibrillator (ICD) has a single lead
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …

Aims To report 5-year outcomes of EFFORTLESS registry patients with early generation
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to
overcome lead-related complications and systemic infections, inherent to transvenous ICD …

Although sex-related differences in the epidemiology, risk factors, clinical characteristics and
outcomes of heart failure are well known, investigations in the past decade have shed light …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) is associated
with fewer lead-related complications than a transvenous ICD; however, the subcutaneous …

Background Leadless cardiac pacemakers (LCPMs) are an emerging alternative to TV-PM 1–
3 to reduce the complications related to TV leads and subcutaneous generator pockets. 4–6 …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …

Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …